What We Do
Accelerate Product Innovation and Availability
Advocate for Health Equity
Centering Communities, GPP & More
Support a Global Movement
Track and Translate the Field
With partners worldwide, we’re pushing for the funding, implementation and research needed to end HIV and prepare for future pandemics.
Explore our Projects
Prevention Options
Antibody Related Research
Combination Prevention
Condoms
Cure
Microbicides
Multipurpose Prevention Technologies
Post-Exposure Prophylaxis (PEP)
Pre-Exposure Prophylaxis (PrEP)
Testing
Treatment U=U
Vaccines for Prevention
Voluntary Medical Male Circumcision
News, Resources & Events
AVAC v. United States Department of State
Resources
P-Values Blog
PxPulse Podcast
PxWire Quarterly Update
Global Health Watch
Events and Webinars
Press Releases
AVAC in the News
HIV Prevention Clinical Trials Database
HIV Prevention Clinical Trials Map
Translation Index
About Us
Our People
Our Partners
Our Projects
Our Mission and Strategy
Our Commitment to Equity, Diversity and Inclusion
Search
Menu
PrEPWatch.org
HIVResourceTracking.org
STIWatch.org
Engage
Donate
What We Do
Accelerate Product Innovation and Availability
Advocate for Health Equity
Centering Communities, GPP & More
Support a Global Movement
Track and Translate the Field
With partners worldwide, we’re pushing for the funding, implementation and research needed to end HIV and prepare for future pandemics.
Explore our Projects
Prevention Options
Antibody Related Research
Combination Prevention
Condoms
Cure
Microbicides
Multipurpose Prevention Technologies
Post-Exposure Prophylaxis (PEP)
Pre-Exposure Prophylaxis (PrEP)
Testing
Treatment U=U
Vaccines for Prevention
Voluntary Medical Male Circumcision
News, Resources & Events
AVAC v. United States Department of State
Resources
P-Values Blog
PxPulse Podcast
PxWire Quarterly Update
Global Health Watch
Events and Webinars
Press Releases
AVAC in the News
HIV Prevention Clinical Trials Database
HIV Prevention Clinical Trials Map
Translation Index
About Us
Our People
Our Partners
Our Projects
Our Mission and Strategy
Our Commitment to Equity, Diversity and Inclusion
PrEPWatch.org
HIVResourceTracking.org
STIWatch.org
Engage
Donate
Phase 1 Safety & Pharmacokinetic Trial of a Polyurethane Tenofovir Disoproxil Fumarate Intravaginal Ring (IVR)
PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women (MIP)
HVTN 101
A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074
Film Antiretroviral Microbicide Evaluation (FAME-02)
Pre-exposure prevention of viral entry (PREVENT)
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples (PrEP-HIVD)
HVTN 704/HPTN 085 (The AMP Study)
HIV-V-A002 (MENSCH)
Notifications